Experienced in Nonbacterial Prostatitis

Yao-chi C. Chuang

123, Ta Pei Road, Niaosung, 
Kaohsiung, KHQ, TW 
Experienced in Nonbacterial Prostatitis
123, Ta Pei Road, Niaosung, 
Kaohsiung, KHQ, TW 
OverviewLocationsClinical Research

Overview

Yao-chi Chuang practices in Kaohsiung, Taiwan. Chuang is rated as an Experienced expert by MediFind in the treatment of Nonbacterial Prostatitis. Their top areas of expertise are Urinary Incontinence, Interstitial Cystitis, Stress Urinary Incontinence, Vitrectomy, and Nephrectomy.

Their clinical research consists of co-authoring 103 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Nonbacterial Prostatitis.

Locations

123, Ta Pei Road, Niaosung, Kaohsiung, KHQ, Taiwan
Other Locations
Taiwan
Taoyuan, TNQ, Taiwan
Jiayi Shi, TNQ, Taiwan
Taoyuan City, TNQ, Taiwan
Hualien City, TNQ, Taiwan
Taitung, TNQ, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

An Open-Label, Single-Arm, Multi-center Phase II Study to Evaluate the Efficacy and Safety of TLC388 in Patients With Advanced/Metastatic Renal Cell Carcinoma
An Open-Label, Single-Arm, Multi-center Phase II Study to Evaluate the Efficacy and Safety of TLC388 in Patients With Advanced/Metastatic Renal Cell Carcinoma
Enrollment Status: Completed
Publish Date: June 26, 2018
Intervention Type: Drug
Study Phase: Phase 2

103 Total Publications

10-year oncological outcomes of EBRT versus HIFU for stage II prostate cancer: a multicenter Chang Gung research database (CGRD) study with inverse-probability-of-treatment weighting (IPTW) analysis.
10-year oncological outcomes of EBRT versus HIFU for stage II prostate cancer: a multicenter Chang Gung research database (CGRD) study with inverse-probability-of-treatment weighting (IPTW) analysis.
Journal: International urology and nephrology
Published: May 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Chuang's expertise for a condition
ConditionClose
    View All 16 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile